+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Argentina Mammography - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • PDF Icon

    Report

  • 78 Pages
  • August 2026
  • Region: Argentina
  • Mordor Intelligence
  • ID: 5937876
The argentina mammography market size was valued at USD 24.99 million in 2025 and estimated to grow from USD 27.17 million in 2026 to reach USD 41.27 million by 2031, at a CAGR of 8.72% during the forecast period (2026-2031). This report is Segmented by Product Type (Digital Mammography Systems, Analog Mammography Systems, Others), Technology (2-D Full-Field Digital Mammography (FFDM), 3-D Digital Breast Tomosynthesis, Phase-Contrast & Spectral Mammography), End-User (Hospitals, Diagnostic Imaging Centers, Others). The Market Forecasts are Provided in Terms of Value (USD).

Argentina Mammography Market Trends and Insights

Growing Burden of Breast Cancer

Breast cancer incidence in Argentina has reached 73 cases per 100,000 women, while mortality stands at 17.6 per 100,000, making the disease the country’s most prevalent female cancer. Public-health economists estimate that enhanced screening and therapy could avert half of premature cancer deaths and raise national life expectancy by 10 months. Even after a decade of organized screening, 30% of new cases still present at late stages, underscoring a sizeable gap in diagnostic capacity that keeps hospitals and imaging centers upgrading equipment. Population aging will swell per-capita oncology spending by 70% between 2023 and 2050, reinforcing long-term demand for mammography systems. The concentration of both cancer incidence and medical infrastructure in Buenos Aires and Córdoba magnifies regional equipment needs.

Technological Advancements in Digital & 3-D Imaging

Ten-year clinical evidence shows DBT detects 20-65% more invasive tumors and trims false-positive recalls from 10.6% to 7.2% relative to 2-D studies. A dataset of 272,938 screenings reported a 5.3% cancer-detection rate for DBT versus 4.0% for digital mammography, while advanced-stage findings fell sharply. Private clinics in Buenos Aires and Mendoza quickly translated these gains into new procurement cycles, often bundling AI-assisted image-analysis software that lifts detection a further 20%. This technical edge compresses replacement timelines for analog units and establishes new performance baselines influencing both public tenders and private upgrades.

High Upfront Cost of 3-D Systems for Public Hospitals

A DBT console can cost USD 85,000-275,000, a formidable outlay for facilities financed by provincial budgets that devote limited capital to high-tech upgrades. Public health spending equals only 2.19% of GDP, and roughly 17 million Argentines remain uninsured, forcing policymakers to prioritize essential services over advanced imaging. Urban-rural resource imbalances further tilt allocations toward Buenos Aires, leaving provincial hospitals dependent on refurbished equipment or donor programs for modernization. As a result, analog and first-generation digital machines persist in many public sites, sustaining a two-tier care environment.

Other drivers and restraints analyzed in the detailed report include:

  • Expansion of National Breast-Cancer Screening Program
  • Reimbursement for DBT Boosting Hospital Demand
  • Roll-Out of Mobile Mammography Units in Rural Provinces
  • Irregular Reimbursement Cycles in Public Healthcare

Segment Analysis

Digital platforms held 60.72% of Argentina mammography market share in 2025, reflecting decisive migration away from analog units. Hospitals and imaging centers underscore the clinical benefits of higher resolution and lower radiation, while software upgrades extend equipment life cycles. Analog machines remain common in smaller provincial hospitals but continue to lose ground as refurbished digital units become affordable during currency swings. The “Others” category - including contrast-enhanced mammography and breast-specific gamma imaging - records the fastest CAGR at 9.38%, suggesting experimentation beyond traditional x-ray modalities. Regulatory hurdles from ANMAT, such as Spanish-language labeling and certificate-of-free-sale requirements, raise entry barriers, favoring vendors with established local partners. Portable digital detectors, fitted into mobile vans serving remote provinces, demonstrate superior diagnostic yield compared with older computed-radiography plates, fostering a parallel mobile-screening market.

Locally refurbished digital systems satisfy budget constraints for many public hospitals, providing compliant image quality without the premium price of new imports. Currency devaluation amplifies this value proposition and sustains a domestic refurbishment ecosystem that refurbishes, certifies, and services units originally sourced from high-income markets.

Complete Report Scope:

  • By Product Type
    • Digital Mammography Systems
    • Analog Mammography Systems
    • Others
  • By Technology
    • 2-D Full-Field Digital Mammography (FFDM)
    • 3-D Digital Breast Tomosynthesis
    • Phase-Contrast & Spectral Mammography
  • By End-User
    • Hospitals
    • Diagnostic Imaging Centers
    • Others

List of Companies Covered in this Report:

  • Hologic
  • GE Healthcare
  • Siemens Healthineers
  • Fujifilm Holdings Corp.
  • Canon
  • Koninklijke Philips
  • Carestream Health
  • Planmed
  • IMS Giotto S.p.A.
  • Metaltronica
  • Samsung Medison Co. Ltd.
  • Hitachi Ltd. (Medical Imaging)
  • Agfa-Gevaert
  • Koning
  • Allengers Medical Systems Ltd.
  • Analogic Corp. (BK Medical)
  • Mindray
  • Shimadzu
  • Trivitron Healthcare
  • Ziehm Imaging

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents

1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Burden Of Breast Cancer
4.2.2 Technological Advancements In Digital & 3-D Imaging
4.2.3 Expansion Of National Breast-Cancer Screening Program
4.2.4 Reimbursement For Dbt Boosting Hospital Demand
4.2.5 Roll-Out Of Mobile Mammography Units In Rural Provinces
4.2.6 Currency Devaluation Favoring Locally Refurbished Systems
4.3 Market Restraints
4.3.1 Radiation-Exposure Concerns Among Patients
4.3.2 High Upfront Cost Of 3-D Systems For Public Hospitals
4.3.3 Irregular Reimbursement Cycles In Public Healthcare
4.3.4 Import Restrictions And Customs Delays For Imaging Devices
4.4 Value / Supply-Chain Analysis
4.5 Regulatory Landscape
4.6 Technological Outlook
4.7 Porter’s Five Forces
4.7.1 Threat of New Entrants
4.7.2 Bargaining Power of Buyers/Consumers
4.7.3 Bargaining Power of Suppliers
4.7.4 Threat of Substitute Products
4.7.5 Intensity of Competitive Rivalry
5 Market Size & Growth Forecasts (Value, USD)
5.1 By Product Type
5.1.1 Digital Mammography Systems
5.1.2 Analog Mammography Systems
5.1.3 Others
5.2 By Technology
5.2.1 2-D Full-Field Digital Mammography (FFDM)
5.2.2 3-D Digital Breast Tomosynthesis
5.2.3 Phase-Contrast & Spectral Mammography
5.3 By End-User
5.3.1 Hospitals
5.3.2 Diagnostic Imaging Centers
5.3.3 Others
6 Competitive Landscape
6.1 Market Concentration
6.2 Market Share Analysis
6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
6.3.1 Hologic Inc.
6.3.2 GE Healthcare
6.3.3 Siemens Healthineers AG
6.3.4 Fujifilm Holdings Corp.
6.3.5 Canon Medical Systems Corp.
6.3.6 Koninklijke Philips N.V.
6.3.7 Carestream Health Inc.
6.3.8 Planmed Oy
6.3.9 IMS Giotto S.p.A.
6.3.10 Metaltronica S.p.A.
6.3.11 Samsung Medison Co. Ltd.
6.3.12 Hitachi Ltd. (Medical Imaging)
6.3.13 Agfa-Gevaert N.V.
6.3.14 Koning Corporation
6.3.15 Allengers Medical Systems Ltd.
6.3.16 Analogic Corp. (BK Medical)
6.3.17 Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
6.3.18 Shimadzu Corp.
6.3.19 Trivitron Healthcare
6.3.20 Ziehm Imaging GmbH
7 Market Opportunities & Future Outlook
7.1 White-space & Unmet-need Assessment

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Hologic Inc.
  • GE Healthcare
  • Siemens Healthineers AG
  • Fujifilm Holdings Corp.
  • Canon Medical Systems Corp.
  • Koninklijke Philips N.V.
  • Carestream Health Inc.
  • Planmed Oy
  • IMS Giotto S.p.A.
  • Metaltronica S.p.A.
  • Samsung Medison Co. Ltd.
  • Hitachi Ltd. (Medical Imaging)
  • Agfa-Gevaert N.V.
  • Koning Corporation
  • Allengers Medical Systems Ltd.
  • Analogic Corp. (BK Medical)
  • Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
  • Shimadzu Corp.
  • Trivitron Healthcare
  • Ziehm Imaging GmbH